Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Bronchoalveolar lavage fluid concentrations of MMP-7, IL-4Rα, PAR-2 and TNF-α in the whole group at the time of diagnosis and in progressor and nonprogressor subgroups

From: Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients

  EAA -whole group n = 71 Progressors n = 14 Nonprogressors n = 34
MMP-7 (ng/ml) 2.26 (0.24–5.37)
2.54 ± 1.77
1.93 (0.59–7.68)
2.72 ± 2.47
2.23 (0.24–5.37)
2.48 ± 1.52
IL-4Rα (pg/ml) 745.3 (0–2365.0)
723.11 ± 716.67
758.0 (32.0–2342.0)
1003.4 ± 863.1
451.0 (0–2365.0)
633.6 ± 648.8
PAR-2 (ng/ml) 827.0 (279.0–10,000.0)
2192.89 ± 2654.1
1163.0 (451.0–7353.2)
1796.7 ± 1947.5
1377.8 (279.0–\.0)
2311.7 ± 2838.1
TNF-α (pg/ml) 2.89 (0–7.58)
2.88 ± 2.82
2.17 (0–5.32)
2.54 ± 2.42
3.45 (0–7.56)
2.91 ± 2.43
  1. EAA Extrinsic allergic alveolitis, MMP-7 Matrix metalloproteinase 7, IL-4Rα Interleukin 4 receptor α, PAR-2 Protease activated receptor 2, TNF-α Tumor necrosis factor α. Data are expressed as median (min-max) and mean ± SD